US2005186148A1PendingUtilityA1
Incorporation of exogenous lactic bacteria into the oral microflora
Priority: Aug 12, 1998Filed: Mar 23, 2005Published: Aug 25, 2005
Est. expiryAug 12, 2018(expired)· nominal 20-yr term from priority
Inventors:Jean-Richard NeeserBernhard GuggenheimElena-Maria ComelliFrancesca StingelePier Cocconcelli
A61P 43/00A61P 1/02A23C 9/123A61Q 11/00A23C 9/1236A61K 8/99
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions for the prophylaxis or treatment of dental caries, dental plaque, and periodontal infection that include lactic bacteria that are not part of the resident microflora of the mouth, that are low acidifying, and that are capable of adhering directly to the pellicle of the teeth. The compositions are used in methods of treating or preventing dental caries, dental plaque, and periodontal infection.
Claims
exact text as granted — not AI-modified1 . A method of treating or preventing dental caries, dental plaque, and periodontal infection in humans or animals comprising administering to the oral cavity of a human or animal one or more lactic bacteria that are not part of the resident microflora of the human mouth, that are low acidifying in that when administered they provide a pH in the oral cavity of 5.5 to 7, and that are capable of adhering directly to the pellicle of the teeth to displace from the teeth or prevent attachment to the teeth of cariogenic strains of bacteria that are resident microflora of the mouth.
2 . The method of claim 1 , wherein the lactic bacteria are originally derived from a diary.
3 . The method of claim 1 , wherein the lactic bacteria comprise one or more of Streptococcus thermophilus,llactococcus lactis subsp. lactis , or Lactococcus lactis subsp. lactis biovar diacetylactis.
4 . The method of clam 1 , wherein the lactic bacteria have optimal growth at a temperature of 30° C. to 42° C.
5 . The method of claim 1 , wherein the lactic bacteria have been genetically modified to have improved adherence to the pellicle of the teeth by insertion of the X17390 gene, the X14490 gene, or the X53657 gene.
6 . The method of claim 1 , further comprising administering the lactic bacteria in combination with one or more of milk, fermented milk, milk derivatives, or bacteriocin.
7 . The method of claim 6 , wherein the milk derivative comprises one or more of a caseino-glycomacropeptide, micellar casein, fluorinated micellar casein, or renneted milk.
8 . The method of claim 1 , wherein the lactic bacteria that are used for treating or preventing dental caries are administered by way of a composition that contains the lactic bacteria in an amount of 10 4 to 10 9 cfu/g in order to provide the pH of at least 5.5 when the composition is administered to the oral cavity of a human or animal.
9 . The method of claim 8 , wherein the composition further contains one or more of milk, fermented milk, or a milk derivative.
10 . The method of claim 9 , which further comprises a bacteriocin in an amount of 0.00001 to 50 percent by weight of the composition.
11 . The method of claim 10 , wherein the composition includes a milk derivative comprising one or more of a caseino-glycomacropeptide, micellar casein, fluorinated micellar casein, or renneted milk in an amount of at least 0.1 percent by weight of the composition.
12 . The method of claim 8 , wherein the composition further comprises one or more of an oil soluble antioxidant or an abrasive.
13 . The method of claim 8 , wherein the composition is in the form of a toothpaste, mouth rinse, gum, spray, beverage, candy, infant formula, ice cream, frozen dessert, sweet salad dressing, milk preparation, cheese, quark, yogurt, acidified milk, coffee cream or whipped cream.Join the waitlist — get patent alerts
Track US2005186148A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.